Study of Tissue and Blood Samples From Patients With Low-Grade Glioma - Trial NCT01004523
Access comprehensive clinical trial information for NCT01004523 through Pure Global AI's free database. This phase not specified trial is sponsored by Alliance for Clinical Trials in Oncology and is currently Completed. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 135 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Alliance for Clinical Trials in Oncology
Timeline & Enrollment
N/A
Dec 01, 1995
Mar 01, 2013
Primary Outcome
Alterations in chromosomes 7, 9p, 10, 17, 19q, X, or Y as determined by FISH,Loss of chromosomal materials in chromosomes 9p, 10, 13, 17, or 22 by PCR analysis,Levels of PCNA, Ki-67 (MIB-1), or mutated p53 by immunostaining with monoclonal antibodies,DNA ploidy by FISH and flow cytometry,Percentage of cells in S-phase or G2M-phase as measured by flow cytometry
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the
 laboratory may help doctors learn more about changes that occur in DNA and identify
 biomarkers related to cancer. It may also help doctors predict how patients will respond to
 treatment.
 
 PURPOSE: This research study is looking at tissue and blood samples from patients with
 low-grade glioma.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01004523
Non-Device Trial